HBK Sorce Advisory’s Vivani Medical VANI Stock Holding History

HBK Sorce Advisory’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,167	Closed	-$74K	–	457
2019 Q4	$74K	Hold	4,167	–	–	0.01%	432
2019 Q3	$82K	Hold	4,167	–	–	0.01%	400
2019 Q2	$80K	Hold	4,167	–	–	0.01%	403
2019 Q1	$80K	Sell	4,167 -21	-0.5%	-$409	0.01%	422
2018 Q4	$89K	Buy	4,188 +625	+18%	+$19.9K	0.01%	375
2018 Q3	$162K	Sell	3,563 -625	-15%	-$25.2K	0.02%	386
2018 Q2	$167K	Buy	4,188 +21	+0.5%	+$914	0.02%	369
2018 Q1	$192K	Buy	4,167 +224	+6%	+$9.96K	0.02%	357
2017 Q4	$181K	Buy	3,943 +2,901	+278%	+$96.4K	0.02%	375
2017 Q3	$30K	Buy	+1,042	New	+$29.1K	﹤0.01%	317

Other funds holding VANI

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

HBK Sorce Advisory's VANI Position: Q1 2020 in Review

HBK Sorce Advisory sold out of Vivani Medical (VANI) in Q1 2020, closing a stake of 4,167 shares — an estimated $74K sold.

HBK Sorce Advisory first reported a position in VANI in Q3 2017 and held it in 10 quarters. The position peaked at $192K in Q1 2018. 21 funds tracked by Wall St. Rank hold VANI as of Q1 2020.

HBK Sorce Advisory reported no remaining Vivani Medical position as of Q1 2020 after selling out during the quarter.
HBK Sorce Advisory sold 4,167 Vivani Medical shares in Q1 2020, an estimated $74K.
HBK Sorce Advisory first reported a position in Vivani Medical in Q3 2017 and held it in 10 quarters.
HBK Sorce Advisory's Vivani Medical position peaked at $192K in Q1 2018.
21 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2020.

Based on HBK Sorce Advisory's 13F filing for Q1 2020, filed 15 May 2020.